XSHE
300132
Market cap413mUSD
Jul 10, Last price
5.70CNY
1D
1.42%
1Q
-31.82%
Jan 2017
-45.59%
IPO
-41.52%
Name
Fujian Green Pine Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fujian Green Pine Co., Ltd. focuses on the entire lifecycle of turpentine derivatives, from initial research and development through to manufacturing and sales. Their extensive product line encompasses a wide array of chemical compounds, such as synthetic camphor, isobornyl acetate, camphene, borneol flakes, para cymene, pinene, dipentene, isoborneol, both crystalline and anhydrous sodium acetate, isobornyl (meth) acrylate, myrcene, benzyl acetate, QS keton, and various solvent oils. These products find diverse applications across sectors including flavorings, fragrances, pharmaceuticals, personal care items, cleaning solutions, and paints and coatings. The company maintains a global presence, conducting business across Asia, Europe, North America, South America, Oceania, and Africa. Established in 1958, the firm is headquartered in Jianyang, China, and adopted its current name, Fujian Green Pine Co., Ltd., in May 2009, having previously been known as Jianyang City Green Pine Chemical Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||